GlassScriptPhysician profile
Alicia Salyer
NPI 1699738674
$1,481.38
in general payments reported to CMS, 2019-2025
19 companies · $203 in 2025
The $203 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2020: $39.21 · 2021: $182 · 2022: $314 · 2023: $418 · 2024: $197 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $818.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $422.14 | 2021-2025 | Qelbree, Qelbree |
| Corium, LLC | $257.19 | 2021-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $154.36 | 2019-2024 | Jornay Pm |
| Pfizer INC. | $135.01 | 2019-2024 | |
| Seqirus USA INC | $119.55 | 2022-2025 | Flucelvax |
| Takeda Pharmaceuticals U.S.A., INC. | $74.39 | 2020-2021 | |
| Glaxosmithkline, LLC. | $66.88 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $62.18 | 2025 | Jornay Pm |
| Adlon Therapeutics L.P. | $35.04 | 2021 | |
| Merck Sharp & Dohme LLC | $25.65 | 2020-2024 | Vaxneuvance, Gardasil, Gardasil 9 |
| Ultragenyx Pharmaceutical INC. | $19.36 | 2022 | |
| Genentech USA, INC. | $18.39 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.84 | 2024 | Zoryve |
| Tris Pharma INC | $15.01 | 2021 | |
| Sanofi Pasteur INC. | $13.25 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $12.60 | 2021 | |
| Arbor Pharmaceuticals, INC. | $11.93 | 2019 | |
| Kaleo, INC. | $11.77 | 2022 | |
| Shire North American Group INC | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alicia Salyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.